Senior MD, Accenture Life Sciences
By Sander van‘t Noordende, group chief executive of Accenture’s products operating group
Socioeconomic trends, healthcare consumerization, and new technology and science landscapes are presenting an exciting opportunity for the life sciences industry and the more than 7 billion people in the world it touches. Anne is leading the charge to turn industry change into opportunities for life sciences companies and the patients they serve.
As she puts it, “It is my passion and belief that through commitments to collaboration and disruption along nontraditional lines, we can improve the standard of care on a global scale.”
With nearly 30 years of experience, Anne is charged with growing and developing Accenture’s global life sciences practice. Under her leadership, the group has seen double-digit growth each year.
Anne oversees a global team of more than 15,000 people in more than 50 countries. It is a team that actively helps 95% of the Fortune 500 life sciences companies in the top 10 global pharmaceutical markets deliver improved outcomes and patient care around the world.